{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-006127","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2022-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.300778+00:00","generated_at":"2026-06-26T23:08:35.952757+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Puma Biotechnology raises $10M via private placement with CEO and Athyrium","bullets":["Sold 3,584,228 shares at $2.79 each to CEO Alan Auerbach and an Athyrium fund for $10M gross proceeds.","Each purchaser committed ~$5M; placement closed March 10, 2022, at closing price.","Proceeds will be used for general corporate purposes; company to file resale registration statement within 135 days.","Private placement exempt from registration under Section 4(a)(2) of Securities Act.","CEO Auerbach participated alongside Athyrium, an existing noteholder affiliate."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-006127","json":"https://secwatch.observer/filing/0001437749-22-006127.json","markdown":"https://secwatch.observer/filing/0001437749-22-006127.md","text":"https://secwatch.observer/filing/0001437749-22-006127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922006127/0001437749-22-006127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922006127/pbyi20220310_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T23:08:35.952757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}